Valacyclovir

Valacyclovir

SCHEMBL28644

CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
HBB P68871 2/20 0.98
MAPK1 P28482 1/20 0.98
PDE3A Q14432 1/20 0.70
PNP P00491 7/20 0.67
BLM P54132 2/20 0.67
TSHR P16473 2/20 0.67
USP2 O75604 1/20 0.67
EDNRA P25101 1/20 0.67
HTR2A P28223 1/20 0.67
RECQL P46063 1/20 0.67
HSD17B10 Q99714 1/20 0.67
HPRT1 P00492 7/20 0.61
POLG P54098 1/20 0.59
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
CYP3A4 P08684 1/20 0.56
NFKB1 P19838 1/20 0.56
VCP P55072 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valacyclovir SCHEMBL8444387 1.00 MEN1 (1.00) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL13575743 1.00 MEN1 (1.00) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL4656778 1.00 MEN1 (1.00) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL5724652 0.99 MEN1 (0.98) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL4347901 0.99 MEN1 (0.98) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL5194177 0.99 MEN1 (0.98) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL40830 0.99 HBB (1.00) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL725136 0.99 HBB (1.00) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL8320611 0.99 HBB (1.00) MEN1KMT2AHBBMAPK1PDE3A
Valacyclovir SCHEMBL1560193 0.99 HBB (1.00) MEN1KMT2AHBBMAPK1PDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 28008 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144816-A1 COMPOSITIONS AND METHODS FOR TREATING DEMENTIA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2026-05-28 US claimed
US-12636378-B2 Targeted antigen delivery system and uses thereof SRI INTERNATIONAL (US) 2026-05-26 US claimed
US-20260139860-A1 PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS CENTRE FOR DIGESTIVE DISEASES (AU) 2026-05-21 US claimed
WO-2026106917-A1 EDIBLE TRANSMUCOSAL DRUG DELIVERY METHOD USING AN INTERMEDIATE CAPSULE AS A TEMPORARY VESSEL BioPhysics Pharma, Inc. (US) 2026-05-21 WO claimed
US-20260137669-A1 NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS INNOVATIVE MOLECULES GMBH (DE) 2026-05-21 US claimed
EP-4094767-B1 NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO UNIV EMORY (US) 2026-05-20 EP claimed
US-12631653-B2 Methods for diagnosing and treating uveitis THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2026-05-19 US claimed
US-20260131028-A1 COMBINATION CANCER THERAPY DELTA NEXT GENE LLC (US) 2026-05-14 US claimed
US-20260124148-A1 POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY BHAMIS RES LABORATORY PVT LTD (IN) 2026-05-07 US claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
WO-1996024354-A1 NOVEL PHARMACEUTICAL COMPOSITION ASTRA AKTIEBOLAG (SE) 1996-08-15 WO claimed
EP-0723448-A1 USE OF PENICLORIN FOR THE TREATMENT OF POSTTHERAPEUTIC NEURALGIA SMITHKLINE BEECHAM PLC (GB) 1996-07-31 EP claimed
WO-1996022082-A1 VALACICLOVIR TABLETS CONTAINING COLLOIDAL SILICON DIOXIDE THE WELLCOME FOUNDATION LIMITED (GB) 1996-07-25 WO claimed
WO-1996022291-A1 GUANINE DERIVATIVE THE WELLCOME FOUNDATION LIMITED (GB) 1996-07-25 WO claimed
WO-1996020171-A1 ANTIHERPES PEPTIDOMIMETIC COMPOUNDS BOEHRINGER INGELHEIM (CANADA) LTD./BOEHRINGER INGELHEIM (CANADA) LTÉE (CA) 1996-07-04 WO claimed
WO-1996018397-A1 THE TREATMENT OF AUTOIMMUNE DISEASE USING 2-AMINO PURINE DERIVATIVES EXLEY RAY W (US) 1996-06-20 WO claimed
WO-1995011027-A1 USE OF PENICLORIN FOR THE TREATMENT OF POSTTHERAPEUTIC NEURALGIA SMITHKLINE BEECHAM PLC (GB) 1995-04-27 WO claimed
WO-1995005179-A1 THERAPEUTIC COMBINATION CONTAINING AN ANTI-VARICELLA ZOSTER VIRUS COMPOUND AND LAMOTRIGINE THE WELLCOME FOUNDATION LIMITED (GB) 1995-02-23 WO claimed
EP-0308065-B1 Therapeutic nucleosides WELLCOME FOUND (GB) 1995-01-04 EP claimed
US-4957924-A VIRICIDES, ACYCLOVIR GENERATION BURROUGHS WELLCOME CO. (US) 1990-09-18 US claimed